Association of cigarette smoking with metabolic syndrome (MetS): A review
Bioinformation · 31.10.2026 · 22 (10) · 7619-7623
DOI: 10.6026/973206300227619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Nishath Sayed Abdul.
Abstract (Originalsprache)
Metabolic syndrome combines central adiposity, dyslipidaemia, dysglycaemia and elevated blood pressure. Cigarette smoking may affect metabolic risk through inflammatory and autonomic pathways. Therefore, it is of interest to examine the epidemiological associations, mechanisms and cessation effects. Low HDL cholesterol and raised triglycerides are recurrent associations; other findings vary. Smoking cessation remains essential, while longitudinal metabolic research is still needed.
Zitieren
APA
Abdul, N. S. (2026). Association of cigarette smoking with metabolic syndrome (MetS): A review. Bioinformation, 22(10), 7619-7623. https://doi.org/10.6026/973206300227619
Vancouver
Abdul NS. Association of cigarette smoking with metabolic syndrome (MetS): A review. Bioinformation. 2026;22(10):7619-7623. doi:10.6026/973206300227619
BibTeX
@article{Abdul2026,
author = {Abdul, Nishath Sayed},
title = {Association of cigarette smoking with metabolic syndrome (MetS): A review},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {7619--7623},
doi = {10.6026/973206300227619}
}
EUVIMED